CIA
JUNO

Capital Impact Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital Impact Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,602
Closed -$1.26M – 162
2017
Q4 		$1.26M Hold
27,602
– – 0.55% 98
2017
Q3 		$1.24M Buy
+27,602
New +$941K 0.55% 106

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capital Impact Advisors's JUNO Position: Q1 2018 in Review

Capital Impact Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 27,602 shares — an estimated $1.26M sold.

Capital Impact Advisors first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $1.26M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Capital Impact Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital Impact Advisors sold 27,602 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.26M.
  • Capital Impact Advisors first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Capital Impact Advisors's Juno Therapeutics, Inc. position peaked at $1.26M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital Impact Advisors's 13F filing for Q1 2018, filed 11 Apr 2018.